Ophthalmology News

Ophthal

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Manjappa AS et al. – The formulation with benzalkonium chloride and edetate disodium improved the rate of corneal absorption but not the extent. The developed formulation is a viable alternative to conventional eye drops by virtue of its ability to enhance bioavailability through its longer precorneal residence time and ability to sustain drug release. Also importantly is the ease of instillation afforded and decreased frequency of instillation resulting in better patient acceptance.

Related Articles

Ketorolac tromethamine 0.4% to relieve eye pain and inflammation following cataract extraction and keratorefractive surgery
Expert Review of Ophthalmology, 10/22/09    Relevance Score: 84%

Today in Clinical Pharmacology...keeping you current

Intravitreal injection of bevacizumab and triamcinolone acetonide at the end of vitrectomy for diabetic vitreous hemorrhage: a comparative study
Graefe's Archive for Clinical and Experimental Ophthalmology, 12/16/09

Intravitreal bevacizumab to facilitate vitrectomy in idiopathic ischaemic retinal vasculitis
International Ophthalmology, 12/16/09

Concentration of cytokines in age-related macular degeneration after consecutive intravitreal bevacizumab injection
Graefe's Archive for Clinical and Experimental Ophthalmology, 12/16/09

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address